Overview access related issues

We have identified several issues that can be the origin of a highly priced medicine. Please find an overview of all issues below.

Access problems due to monopoly
* Patent or IP legislation
* Supplementary protection certificates
* Data exclusivity
* Orphan market exclusivity
* Only one product registered
* No generic or therapeutic competition
* Supply chain issues
* API monopoly
Access problems due to high prices
* High prices due to monopoly
* High prices not due to monoply 
* High production costs
* High ingredient costs
Access problems due to other barriers
* Weak health system
* Weak distribution system
* Registration barriers
* Financing or insurance barriers